Therapeutic Combinations Of Nicotinic Acid And Meldonium


The present invention comprises a synergistic combination of nicotinic acid and meldonium characterized by increased efficiency in treating disorders, including platelet aggregation, dyslipidemia, hyperlipidemia, atherosclerosis, coronary heart disease as chosen from the group of angina pectoris and myocardial infarction, transient and permanent ischemic attack including cerebrovascular accident and stroke and peripheral arterial occlusive disease, and by reduced flushing effect and/or increase of blood glucose levels, comprising as active ingredients nicotinic acid or pharmaceutically acceptable salt thereof and meldonium or pharmaceutically acceptable salt thereof, effective for said purpose.

Download PDF
Document Preview
Document History
  • Publication: Dec 29, 2010
  • Application: Jun 21, 2010
    WO LV 2010000008 W
  • Priority: Jun 21, 2010
    LV LV 100094 A
  • Priority: Jun 25, 2009
    LV LV 090116 A

Download Citation

Sign in to the Lens